Japan's MHLW Requests Imovax Price Cut; More Than Double U.S.
This article was originally published in PharmAsia News
Before the switch to inactivated polio vaccines for routine polio inoculation in September, the Ministry of Health, Labor, and Welfare plans to reach out to vendor Sanofi Pasteur in an attempt to slash the prices for its single IPV Imovax.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
The combination of bupivacaine and meloxicam will be priced at a discount to Exparel, with Heron predicting rapid uptake. Label limited to three surgery types, but analysts expect off-label use.
Increasing number of product development meetings suggests that many complex generics remain in the development stages.